Literature DB >> 12410197

Efficacy of zinc-fortified oral rehydration solution in 6- to 35-month-old children with acute diarrhea.

Rajiv Bahl1, Nita Bhandari, Manju Saksena, Tor Strand, Geeta T Kumar, Maharaj K Bhan, Halvor Sommerfelt.   

Abstract

OBJECTIVE: To determine the efficacy of zinc-fortified oral rehydration salts solution (ORS) in comparison to ORS without zinc in 6- to 35-month-old urban children with acute diarrhea not sick enough to be hospitalized.
DESIGN: Double-blind, randomized, controlled trial.
METHODS: Children (n = 1219) with acute diarrhea were randomly assigned to one of 3 groups. The first group received a zinc syrup (15 mg zinc to 6- to 11-month-old children and 30 mg to 12- to 35-month-old children), the second group received zinc premixed with ORS (40 mg/L), and the control children received ORS only. Households were visited twice weekly until recovery.
RESULTS: The total number of stools was lower in the zinc-ORS group (rate ratio, 0.83; 95% CI, 0.71-0.96), as was the proportion of children with watery stools (odds ratio, 0.61; 95% CI, 0.39-0.95), compared with the control group; there was no significant effect on diarrheal duration. ORS intake and proportion of children with vomiting were not significantly different between the zinc-ORS and control groups. The zinc syrup group had lower diarrheal duration (relative hazards, 0.89; 95% CI, 0.80-0.99) and total stools (rate ratio, 0.73; 95% CI, 0.70-0.77) than control children.
CONCLUSIONS: Zinc-ORS was moderately efficacious in reducing the severity of acute diarrhea without increasing vomiting or reducing ORS intake.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410197     DOI: 10.1067/mpd.2002.128543

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  18 in total

Review 1.  Zinc deficiency: what are the most appropriate interventions?

Authors:  Roger Shrimpton; Rainer Gross; Ian Darnton-Hill; Mark Young
Journal:  BMJ       Date:  2005-02-12

Review 2.  Zinc supplementation in acute diarrhea.

Authors:  Ting-Ting Zou; Jing Mou; Xue Zhan
Journal:  Indian J Pediatr       Date:  2014-06-24       Impact factor: 1.967

3.  Demonstration of the effectiveness of zinc in diarrhoea of children living in Switzerland.

Authors:  Pierre Alex Crisinel; Marie-Elise Verga; Konan Sallert Alexis Kouame; Anne Pittet; Céline Gasser Rey-Bellet; Olivier Fontaine; Ermindo Roberto Di Paolo; Mario Gehri
Journal:  Eur J Pediatr       Date:  2015-03-07       Impact factor: 3.183

4.  Serum Zinc Concentrations in Children with Acute Bloody and Watery Diarrhoea.

Authors:  Abolfazl Mahyar; Parviz Ayazi; Victoria Chegini; Mehdi Sahmani; Sonia Oveisi; Shiva Esmaeily
Journal:  Sultan Qaboos Univ Med J       Date:  2015-11-23

5.  Efficacy of zinc in reducing hyperbilirubinemia among at-risk neonates: a randomized, double-blind, placebo-controlled trial.

Authors:  Nidhi Rana; Satish Mishra; Shinjini Bhatnagar; Vinod Paul; Ashok Kumar Deorari; Ramesh Agarwal
Journal:  Indian J Pediatr       Date:  2011-04-01       Impact factor: 1.967

Review 6.  Zinc in child health and disease.

Authors:  Shinjini Bhatnagar; Uma Chandra Mouli Natchu
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

Review 7.  The use of oral rehydration solutions in children and adults.

Authors:  Timothy A Sentongo
Journal:  Curr Gastroenterol Rep       Date:  2004-08

Review 8.  Therapeutic value of zinc supplementation in acute and persistent diarrhea: a systematic review.

Authors:  Archana Patel; Manju Mamtani; Michael J Dibley; Neetu Badhoniya; Hemant Kulkarni
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

Review 9.  Oral zinc for treating diarrhoea in children.

Authors:  Marzia Lazzerini; Humphrey Wanzira
Journal:  Cochrane Database Syst Rev       Date:  2016-12-20

Review 10.  Systematic review of diarrhea duration and severity in children and adults in low- and middle-income countries.

Authors:  Laura M Lamberti; Christa L Fischer Walker; Robert E Black
Journal:  BMC Public Health       Date:  2012-04-06       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.